Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.

European heart journal - 1 Dec 1997

Smalling R W

Abstract excerpt

Thrombolytic therapy has been recognized as a significant improvement in the management of acute myocardial infarction. Thrombolytic agents however have been limited by short half-lives that necessitate complex administration protocols and by the potential for bleeding complications. The native t-PA molecule has since been modified in an attempt to achieve improved lytic characteristics with less risk of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Fibrinolytic Agents
Share to Molecular Sequence Data

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Plasminogen Activators

Share to Recombinant Proteins

Share to Tissue Plasminogen Activator

Source

Identifiers

PMID: 9447335
DOI: 10.1093/eurheartj/18.suppl_f.11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.PMID 9447335Read ↗

Newer thrombolytic agents.Semantic proximity Read ↗

Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.Semantic proximity Read ↗

Properties of a novel plasminogen activator (BM 06.022) produced in Escherichia coli.Semantic proximity Read ↗

Redesigning t-PA for improved thrombolytic therapy.Semantic proximity Read ↗

Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.Semantic proximity Read ↗

Functional properties of a novel mutant of staphylokinase with platelet-targeted fibrinolysis and antiplatelet aggregation activities.Semantic proximity Read ↗

Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.Semantic proximity Read ↗

[Biochemical, pharmacologic and clinical properties of new thrombolytic agents].Semantic proximity Read ↗

Plasminogen mutants activated by thrombin. Potential thrombus-selective thrombolytic agents.Semantic proximity Read ↗

Studies on the regulation of tissue plasminogen activator activity by physiological templatesSemantic proximity Read ↗

Blood-brain barrier permeability and tPA-mediated neurotoxicity.Semantic proximity Read ↗

Tissue-type plasminogen activator: mutants, variants, and adjunctive treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.